Brief: Cyclopharm Sees H1 Revenue To Be About $8.1 MLN, up 45%
July 2 (Reuters) - Cyclopharm Ltd CYC.AX :
* CYCLOPHARM LTD - CYC FIRST HALF TRADING UPDATE-CYC.AX
* CYCLOPHARM LTD - FIRST HALF DIVIDEND EXPECTED TO BE
MAINTAINED
AT 0.5 CENTS PER SHARE.
* CYCLOPHARM LTD-TOTAL UNAUDITED H1 2021 REVENUE EXPECTED TO
BE
ABOUT$8.1 MILLION, AN INCREASE OF 45% COMPARED TO 1H 2020
Source text for Eikon: ID:nASX4prmg
Further company coverage: CYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclopharm
See all newsAustralia's Cyclopharm rises after Chinese medical groups back its Technegas
Australia's Cyclopharm gains most in 8-months on Technegas rollout deal
Australia's Cyclopharm rises on HY revenue forecast
Brief: Cyclopharm Forecasts 1H Global Revenue Of A$17.1 Million
Brief: Cyclopharm Says David Heaney To Retire As Non-Executive Chair